These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12199940)

  • 21. Respiratory syncytial virus infections: recent prospects for control.
    Sidwell RW; Barnard DL
    Antiviral Res; 2006 Sep; 71(2-3):379-90. PubMed ID: 16806515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Syncytial respiratory virus infections and ribavirin].
    Ventura F; Cheseaux JJ; Cotting J; Guignard JP
    Arch Pediatr; 1998 Jul; 5(7):809. PubMed ID: 9759283
    [No Abstract]   [Full Text] [Related]  

  • 24. Asthma and early childhood infectious disease. Infection is trigger rather than cause.
    Angelakou V; Bitsori M; Galanakis E
    BMJ; 2001 Jul; 323(7305):164. PubMed ID: 11463693
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention and treatment of respiratory syncytial virus infections.
    Mills J
    Adv Exp Med Biol; 1999; 458():39-53. PubMed ID: 10549378
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy of respiratory syncytial virus infection.
    DeVincenzo JP
    Pediatr Infect Dis J; 2000 Aug; 19(8):786-90; discussion 802-4, 811-3. PubMed ID: 10959759
    [No Abstract]   [Full Text] [Related]  

  • 27. Reassessment of indications for ribavirin therapy in respiratory syncytial virus infection.
    Steele RW
    Clin Pediatr (Phila); 1996 Jul; 35(7):377. PubMed ID: 8829010
    [No Abstract]   [Full Text] [Related]  

  • 28. Ribavirin therapy of respiratory syncytial virus infections.
    Ameratunga SN; Lennon DR; Asher MI; Spinetto H; Anderson B
    N Z Med J; 1994 May; 107(977):180-2. PubMed ID: 8177576
    [No Abstract]   [Full Text] [Related]  

  • 29. Nationwide survey of palivizumab for respiratory syncytial virus prevention in Japanese children with congenital heart disease.
    Saji T; Nakazawa M; Harada K
    Pediatr Infect Dis J; 2008 Dec; 27(12):1108-9. PubMed ID: 18978515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report.
    Yoon BW; Lee SH
    J Med Case Rep; 2017 Dec; 11(1):353. PubMed ID: 29258592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention.
    Rosenberg HF; Bonville CA; Easton AJ; Domachowske JB
    Pharmacol Ther; 2005 Jan; 105(1):1-6. PubMed ID: 15626452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory syncytial virus infection and recurrent wheezing: a complex relationship.
    Meissner HC; Long SS
    J Pediatr; 2007 Jul; 151(1):6-7. PubMed ID: 17586181
    [No Abstract]   [Full Text] [Related]  

  • 33. Respiratory syncytial virus and asthma. The role of monocytes.
    Kimpen JL
    Am J Respir Crit Care Med; 2001 Mar; 163(3 Pt 2):S7-9. PubMed ID: 11254544
    [No Abstract]   [Full Text] [Related]  

  • 34. The RSV-asthma link: the emerging story. Introduction.
    Eigen H
    J Pediatr; 1999 Aug; 135(2 Pt 2):1. PubMed ID: 10431131
    [No Abstract]   [Full Text] [Related]  

  • 35. [Respiratory syncytial virus infections and ribavirin: the controversy continues].
    Aujard Y
    Arch Pediatr; 1998 Feb; 5(2):107-10. PubMed ID: 10223129
    [No Abstract]   [Full Text] [Related]  

  • 36. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
    Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
    Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
    Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
    J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Update on bronchial hyperreactivity after bronchiolitis].
    Fauroux B
    Arch Pediatr; 2005 Nov; 12 Spec No 3():2-7. PubMed ID: 16421998
    [No Abstract]   [Full Text] [Related]  

  • 39. Respiratory syncytial virus and other respiratory viruses.
    Welliver RC
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S6-10; discussion S10-2. PubMed ID: 12671447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction.
    Panitch HB
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S83-7; discussion S87-8. PubMed ID: 12671457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.